4548
P. Bakó et al. / Tetrahedron: Asymmetry 10 (1999) 4539–4551
(m, 2H, NCH2CH2CH2), 2.25–2.43 (m, 2H, CH2), 2.73–3.01 (m, 6H, 3NCH2), 3.43 (s, 3H, OCH3),
3.52–3.90 (m, 13H, CH and CH2 groups), 4.01–4.10 (m, 4H, 2OCH2), 4.26 (dd, J=10.5 Hz, 1H, H-6),
4.83 (d, J=3.6 Hz, 1H, anomeric-H), 5.0 (s, 1H, OH), 5.50 (s, 1H, PhCH), 7.27–7.43 (m, 5H, Ph); 13C
NMR (CDCl3) δ 28.4 (NCH2CH2CH2), 54.3 (CH2NCH2), 56.4 (NCH2CH2CH2), 64.0 (NCH2CH2CH2),
66.1 (C-5), 68.7 (C-6), 68.8, 68.9, 70.2, 70.3, 72.3, 72.5 (6OCH2 of the macrocycle), 80.9, 81.4 (C-3,
C-4), 81.7 (C-2), 101.2 (PhCH), 102.1 (C-1), 125.9 (PhC-o), 128.2 (PhC-m), 129.0 (PhC-p), 137.3 (PhC-
ipso); FABMS m/z 498 (M+H, 100). Anal. calcd for C25H39O9N: C, 60.36; H, 7.85; N, 2.82%. Found:
C, 60.30; H, 7.79; N, 2.80%.
3.2.4. Methyl-4,6-O-benzylidene-2,3-dideoxy-α-D-glucopyranosido[2,3-h]-N-4-hydroxybutyl-1,4,7,10-
tetraoxa-13-azacyclopentadecane 2h
The purification was carried out by column chromatography with eluent dichloromethane:methanol
20
(100:1→100:5) on silica gel. Yield: 51% (yellow oil); [α] +38.4 (c 1, CH2Cl2); IR (neat) 3120–3600,
D
1
2920, 2875, 1600, 1491, 1236, 1093, 756, 692 cm−1; H NMR (CDCl3) δ 1.54–1.70 (m, 4H, 2CH2),
2.47–2.91 (m, 6H, 3NCH2), 3.37 (s, 3H, OCH3), 3.46–3.93 (m, 20H, CH and CH2 groups), 4.24 (dd,
J=10.5 Hz, 1H, H-6), 4.80 (d, J=3.6 Hz, 1H, anomeric-H), 5.48 (s, 1H, PhCH), 7.23–7.46 (m, 5H, Ph);
FABMS m/z 512 (M+H). Anal. calcd for C26H41O9N: C, 61.05; H, 8.02; N, 2.73%. Found: C, 61.15; H,
8.10; N, 2.70%.
3.2.5. Methyl-4,6-O-benzylidene-2,3-dideoxy-α-D-glucopyranosido[2,3-h]-N-2-methoxyethyl-1,4,7,10-
tetraoxa-13-azacyclopentadecane 2i
The purification was carried out by column chromatography with eluent dichloromethane:methanol
20
D
(10:2) on silica gel. Yield: 44% (yellow crystals); mp 78–79°C (ether); [α] +41.6 (c 1.2, CHCl3); IR
(KBr) 2920, 2876, 1600, 1496, 1388, 1239, 1093, 749, 695 cm−1; 1H NMR (CDCl3) δ 2.71–2.92 (m, 6H,
3NCH2), 3.31 (s, 3H, OCH3), 3.40 (s, 3H, OCH3), 3.46–3.90 (m, 19H, CH and CH2 groups), 4.23 (dd,
1H, J=10.5 Hz, H-6), 4.82 (d, J=3.6 Hz, 1H, anomeric-H), 5.50 (s, 1H, PhCH), 7.23–7.46 (m, 5H, Ph);
CIMS m/z (rel. int.) 498 (M+H, 15), 452 (100); FABMS m/z 498 (M+H). Anal. calcd for C25H39O9N: C,
60.36; H, 7.85; N, 2.82%. Found: C, 60.28; H, 7.80; N, 2.78%.
3.2.6. Methyl-4,6-O-benzylidene-2,3-dideoxy-α-D-galactopyranosido[2,3-h]-N-butyl-1,4,7,10-
tetraoxa-13-aza-cyclopentadecane 3a
The purification was carried out by column chromatography with eluent dichloromethane:methanol
20
D
(100:1→100:5) on silica gel. Yield: 61% (yellow oil); [α] +91.8 (c 1, CHCl3); IR (KBr) 2926, 2869,
1600, 1491, 1368, 1228, 1093, 1031, 749, 693 cm−1; 1H NMR (CDCl3) δ 0.90 (t, J=7.3 Hz, 3H, CH3),
1.27–1.74 (m, 4H, CH2), 2.65–2.88 (m, 6H, 3NCH2), 3.40 (s, 3H, OCH3), 3.48–4.14 (m, 18H, CH and
CH2 groups), 4.36 (dd, J=2.8 Hz, 1H, H-6), 4.86 (d, J=2.6 Hz, 1H, anomeric-H), 5.52 (s, 1H, PhCH),
7.18–7.52 (m, 5H, Ph); 13C NMR (CDCl3) δ 14.0, 20.6, 29.6 (CH3CH2CH2), 54.0, 54.5 (CH2NCH2),
55.0 (OCH3), 56.5 (NCH2), 66.1 (C-5), 68.6 (C-6), 69.2, 69.3, 70.3, 70.4, 72.4, 72.5 (6OCH2 of the
macrocycle), 81.1, 81.6 (C-3, C-4), 81.6 (C-2), 100.0 (C-1), 100.9 (PhCH), 125.9 (PhC-o), 128.2 (PhC-
m), 129.0 (PhC-p), 137.2 (PhC-ipso); FABMS m/z 496 (M+H). Anal. calcd for C26H41NO8: C, 63.03; H,
8.28; N, 2.83%. Found: C, 63.07; H, 8.25; N, 2.80%.
3.2.7. Methyl-4,6-O-benzylidene-2,3-dideoxy-α-D-galactopyranosido-[2,3-h]-N-(2-phenyl)ethyl-1,4,7,
10-tetraoxa-13-azacyclopentadecane 3e
The purification was carried out by column chromatography with eluent dichloromethane:methanol
20
D
(100:5→100:10) on silica gel. Yield: 49% (yellow syrup) [α] +103 (c 1, CHCl3); IR (KBr) 2913,